Goldman Sachs Knock-Out DVA/ DE000GG6Z597 /
10/06/2024 09:28:57 | Chg.+0.04 | Bid11:47:09 | Ask11:47:09 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.91EUR | +1.03% | 3.89 Bid Size: 2,000 |
3.94 Ask Size: 2,000 |
DaVita Inc | 101.6046 USD | 31/12/2078 | Call |
GlobeNewswire
26/04
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
17/11/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
15/08/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
21/03/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
07/03/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
10/02/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
07/10/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
01/10/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
GlobeNewswire
09/09/2021
ACTION BEHAVIOR CENTERS HIRES NEW GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
GlobeNewswire
09/09/2021
Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development